  The vast amount of sequencing data presently available allow the scientific
community to explore a range of genetic variables that may drive and progress
cancer. A myriad of predictive tools has been proposed, allowing researchers
and clinicians to compare and prioritize driver genes and mutations and their
relative pathogenicity. However, there is little consensus on the computational
approach or a golden standard for comparison. Hence, benchmarking the different
tools depends highly on the input data, indicating that overfitting is still a
massive problem. One of the solutions is to limit the scope and usage of
specific tool. However, such limitations forces researchers to walk on a
tightrope between creating and using high-quality tools for a specific purpose
and describing the complex alterations driving cancer. While the knowledge of
cancer development increases every day, many bioinformatic pipelines rely on
single nucleotide variants or alterations in a vacuum without accounting for
cellular compartment, mutational burden, or disease progression. Even within
bioinformatics and computational cancer biology, the research fields work in
silos, risking overlooking potential synergies or breakthroughs. Here, we
provide an overview of databases and datasets for building or testing
predictive tools for discovery of cancer drivers. We introduce predictive tools
for driver genes, driver mutations, and the impact of these based on structural
analysis. Additionally, we suggest and recommend directions in the field to
avoid silo-research, moving in the direction of integrative frameworks.
